Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

News Alerts

February 10, 2017

FDA Approves Biosimilar to Humira

By Kanaaz Pereira kanaazpe

The FDA recently approved a biosimilar (trade name, Amjevita) to Humira (adalimumab). A biosimilar is a biological product that is highly similar to the originator drug, and has no clinical differences in terms of safety and effectiveness. Dr. Edward Loftus , M.D., talks about the potential of this drug to offer patients with chronic inflammatory diseases such as Crohn’s and ulcerative colitis an […]

View full entry

Tags: Amjevita, biosimilar, Crohn's disease, Edward Loftus, FDA, Humira, IBD, ulcerative colitis


May 6, 2016

FDA Approves of Biosimilar to Infliximab

By Kanaaz Pereira kanaazpe

The FDA recently approved of a biosimilar (CT-P13) to infliximab, which is used for treating IBD patients, as well as patients suffering from rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The new drug would be the first biosimilar monoclonal antibody approved in the United States. Dr. Edward Loftus, M.D., explains how biosimilars work, and discusses […]

View full entry

Tags: biosimilar, CT-P13, Edward Loftus, FDA, IBD, infliximab, rheumatoid arthritis


March 24, 2016

The New Birth Trend That’s All About Bacteria

By Kanaaz Pereira kanaazpe

It may sound strange, but some women who give birth by caesarean section (C-section) are covering their newborn in fluid swabbed from their vagina! A baby born vaginally is exposed to a plethora of different bacteria as it comes down the birth canal; these bacteria set up the child’s microbiome, (bacteria in human skin, guts, and […]

View full entry

Tags: bacteria, C-section, cesarean section, IBD, immune system, microbiome, Nature Medicine, Sunanda Kane


December 1, 2015

CCFA Awareness Week: Dec.1-7, 2015

By Kanaaz Pereira kanaazpe

Living with inflammatory bowel disease (IBD) can be difficult, but the right resources and support can make day to day living much easier. The Crohn’s & Colitis Foundation of America (CCFA) is a non-profit, volunteer-driven organization dedicated to finding the cures for Crohn’s Disease and ulcerative colitis. In an effort to raise awareness and support […]

View full entry

Tags: Crohn's & Colitis Foundation of America (CCFA), Crohn's disease, IBD, Jeanne Tung, ulcerative colitis


November 9, 2015

Highlights of ACG’s Annual Scientific Meeting 2015

By Kanaaz Pereira kanaazpe

For five days, from October 16 to October 21, 2015, renowned experts in the field of gastroenterology offered clinical insights and real-world perspectives at the American College of Gastroenterology’s Annual Scientific Meeting in Hawaii. Dr. Sunanda Kane, M.D., summarizes some of the bigger studies that were presented at the meeting, including key research done on 6-mercaptopurine (6-MP), (Purinethol) Azathioprine, […]

View full entry

Tags: American College of Gastroenterology, IBD, Sunanda Kane


August 27, 2015

New Stem Cell Therapy for Crohn’s Fistula

By Kanaaz Pereira kanaazpe

Crohn’s fistula can be a devastating condition with a high recurrence rate. Listen to Mayo Clinic gastroenterologist, William Faubion, M.D., talk about exciting new research that shows how stem cells have been used to successfully treat Crohn’s fistula. This study has been published in Stem Cells Translational Medicine. Read the study online here For more […]

View full entry

Tags: Crohn's disease, Crohn's fistula, IBD, stem cells, Stem Cells Translational Medicine, William Faubion


August 17, 2015

Fecal Transplants for Ulcerative Colitis?

By Kanaaz Pereira kanaazpe

There is currently great interest in treating ulcerative colitis with fecal microbiota transplantation (FMT), which involves transplanting gut fecal bacteria from healthy people into patients with ulcerative colitis. Edward Loftus Jr., M.D., a gastroenterologist at Mayo Clinic, talks about two newly published studies in Gastroenterology; both studies examined the efficacy of fecal microbiota transplantation in ulcerative colitis, but arrived […]

View full entry

Tags: Edward Loftus, fecal transplant, Gastroenterology, IBD, ulcerative colitis


June 4, 2015

Pros and Cons of Imaging Modalities for Pediatric IBD

By Margaret Shepard, Communications Specialist Margaret_Marie

Article appears in June’s Digestive Diseases Update. Inflammatory bowel disease (IBD) is one of the most serious gastrointestinal diseases affecting children in the Western world. It has a complex and variable course, and diagnosis not only includes endoscopy but also small bowel imaging to assess mucosal alterations and transmural involvement as well as response to […]

View full entry


May 29, 2015

Infliximab Quantitation with Reflex to Antibodies to Infliximab

By Margaret Shepard, Communications Specialist Margaret_Marie

From Mayo Medical Laboratories The new Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered to assess a trough level quantitation for evaluation of patients with loss of response to infliximab. Maria Willrich, Ph.D. gives a video overview of […]

View full entry

Tags: IBD, infliximab, Mayo Medical Labs


May 8, 2015

IBD and Stool Testing

By Margaret Shepard, Communications Specialist Margaret_Marie

Sunanda Kane, M.D., discusses stool tests for pediatric and adult patients with inflammatory bowel disease. Specially, Dr. Kane focuses on two proteins that may help identify active inflammation. Read the full study online here. For more information about IBD, visit mayoclinic.org/IBD. Dr. Kane is a gastroenterologist at Mayo Clinic.

View full entry

Tags: IBD, protein, stool testing, Sunanda Kane


Contact Us · Privacy Policy